Purple Biotech reports preclinical data for IM1240 cancer treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. META
4. DPZ
5. IBM
6. CNC
7. KFY
8. SPY
9. MU
10. ENRD

Go back to Purple Biotech reports preclinical data for IM1240 cancer treatment
(NASDAQ: PPBT) Delayed: 1.70 --0 (-0%)
Previous Close $1.70    52 Week High $ 
Open $1.70    52 Week Low $ 
Day High $1.70    P/E N/A 
Day Low $1.70    EPS $ 
Volume 3,881